Investigations of Reproductive Cancers in Women

NCT06527157 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2026-04-09

No results posted yet for this study

Summary

The goal of this study is to create a non-invasive diagnostic test to rule out gynecological cancer in females aged 45 and older with abnormal uterine or postmenopausal bleeding.

Conditions

  • Uterine Cancer

Sponsors & Collaborators

  • PinkDx, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrea Mariani, MD · Mayo Clinic

Eligibility

Min Age
45 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-30
Primary Completion
2026-08-30
Completion
2026-11-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06527157 on ClinicalTrials.gov